Which has grown faster, MRNA or TEVA?

Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus TEVA at 1.19%.

Is MRNA or TEVA more profitable?

TEVA runs the higher net margin — MRNA at -141.43% versus TEVA at 4.08%.

How have MRNA and TEVA total returns compared?

Over the past 5 years, MRNA delivered -17.63% and TEVA delivered -2.67% annualized total return. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Teva Pharmaceutical Industries Limited (TEVA)

A side-by-side comparison of Moderna, Inc. and Teva Pharmaceutical Industries Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.

MRNA

Moderna, Inc.

$58.38B

$147.12HealthcareDelayed quote: Sep 3, 2026, 3:20 PM EDT

TEVA

Teva Pharmaceutical Industries Limited

$42.50B

$36.49HealthcareDelayed quote: Sep 3, 2026, 3:20 PM EDT

Total return — MRNA vs TEVA

growth of $100 · dividends reinvested · last 8y

MRNA +710.8% (+29.9%/yr)TEVA +74.0% (+7.2%/yr)MRNA compounded faster over this window

MRNA TEVA

MRNA vs TEVA: by the numbers

•MRNA is the larger company ($58.38B vs $42.50B market cap).
•TEVA is profitable (4.08% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 1.19% CAGR).

Metrics side by side

Valuation

Metric	MRNA	TEVA
P/E ratio	N/A	62.48
Forward P/E	N/A	18.74
P/S ratio	26.80	2.56
P/B ratio	8.83	5.71
EV / EBITDA	N/A	19.35
FCF yield	N/A	3.04%

Profitability

Metric	MRNA	TEVA
Gross margin	55.35%	52.47%
Operating margin	-158.13%	11.45%
Net margin	-141.43%	4.08%
ROE	-46.61%	9.10%
ROIC	-39.16%	6.79%

Growth (annualized)

Metric	MRNA	TEVA
Revenue CAGR (5Y)	19.33%	1.19%
FCF CAGR (5Y)	N/A	14.58%
Total return CAGR (5Y)	-17.63%	31.54%

Frequently asked

Which has grown faster, MRNA or TEVA?: Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus TEVA at 1.19%.
Is MRNA or TEVA more profitable?: TEVA runs the higher net margin — MRNA at -141.43% versus TEVA at 4.08%.
How have MRNA and TEVA total returns compared?: Over the past 5 years, MRNA delivered -17.63% and TEVA delivered -2.67% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full TEVA analysis Interactive comparison tool

Dig into the metrics

Teva Pharmaceutical Industries P/E ratio Moderna ROE Teva Pharmaceutical Industries ROE Moderna operating margin Teva Pharmaceutical Industries operating margin Moderna revenue growth Teva Pharmaceutical Industries revenue growth Moderna free cash flow Teva Pharmaceutical Industries free cash flow

Moderna & Teva Pharmaceutical Industries appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.